Zowark is a modern hybrid-indica cultivar derived from the parent strain Ozark. Engineered for versatility, this variety is suitable for cultivation in both indoor and outdoor environments, requiring a moderate level of grower expertise. Throughout a flowering cycle of 68 days, the plant produces a high yield, reflecting its optimized genetic heritage. The successful breeding of this variety has already resulted in the development of notable offspring, specifically the Zowark F2 generation.

The phytochemical composition of Zowark is defined by an extensive terpene profile beginning with a primary dominance of limonene, followed by caryophyllene, humulene, and linalool. The secondary and tertiary characteristics are derived from a precise balance of bisabolol, beta-pinene, pinene, caryophyllene-oxide, valencene, myrcene, camphene, borneol, ocimene, and eucalyptol. This complex arrangement of chemical constituents provides a distinct aromatic experience, dictated by the sharp, citrus-forward presence of limonene and the spicy, woody undertones provided by the subsequent caryophyllene and humulene levels.

As a THC-dominant cultivar, Zowark is utilized primarily for its ability to induce feelings of a relaxed, calm, and focused state. These effects make the strain a functional option for consumers seeking therapeutic relief regarding pain, stress, or assistance with sleep. The genetic legacy of the strain continues to evolve through the Zowark F2, reinforcing its established profile as a reliable modern hybrid-indica for both medicinal and recreational applications.